Pfizer, Moderna ask FDA to approve bivalent COVID-19 booster for kids

Pfizer and BioNtech asked the U.S. Food and Drug Administration on Monday to approve their new Omicron-specific COVID-19 vaccine for children ages 5 to 11.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this